This report is an essential first step to formulating priorities which will guide development of a science and research agenda. CDER is currently engaged in a number of efforts to identify priorities among the science needs, gaps that could be addressed through targeted research projects, and evolving science needs. These priorities will be assessed within the broad framework of FDA’s overall regulatory science objectives.
- Enviado mediante la barra Google"
No hay comentarios:
Publicar un comentario